Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

Item 1.01. Entry into a Material Definitive Agreement.

On June 27, 2014, AmSurg Corp., a Tennessee corporation (the "Company"), entered
into an amendment (the "Revolving Credit Agreement Amendment") to its Revolving
Credit Agreement, dated May 28, 2010, as amended (the "Revolving Credit
Agreement"), with the lenders party thereto and SunTrust Bank, in its capacity
as administrative agent ("Administrative Agent") to (i) permit AmSurg Escrow
Corp., a Tennessee corporation and wholly-owned subsidiary of the Company (the
"New Subsidiary") to issue indebtedness to finance a portion of the purchase
price payable in connection with the Sheridan Transaction (as defined in the
Revolving Credit Agreement Amendment), (ii) exempt the New Subsidiary from being
deemed a Subsidiary (as defined in the Revolving Credit Agreement) for purposes
of compliance with the negative covenants contained in the Revolving Credit
Agreement, (iii) exclude any Indebtedness (as defined in the Revolving Credit
Agreement) of the New Subsidiary for purposes of determining compliance with the
financial covenants contained in the Revolving Credit Agreement and (iv) permit
the Company to make investments in the New Subsidiary in an aggregate amount
necessary to pay accrued interest on the Sheridan Acquisition Indebtedness (as
defined in the Revolving Credit Agreement Amendment) through a certain date set
forth in the Revolving Credit Agreement Amendment. The terms of the Revolving
Credit Agreement Amendment are more fully described in the Revolving Credit
Agreement Amendment, a copy of which is filed as Exhibit 10.1 to this Current
Report on Form 8-K and is incorporated herein by reference.

On June 27, 2014, the Company entered into an amendment (the "Note Purchase
Agreement Amendment") to its Note Purchase Agreement, dated May 28, 2010, as
amended (the "Note Purchase Agreement"), with the holders of Notes (as defined
in the Note Purchase Agreement) (the "Noteholders") to (i) permit the New
Subsidiary to issue indebtedness to finance a portion of the purchase price
payable in connection with the Sheridan Transaction (as defined in the Note
Purchase Agreement Amendment), (ii) exempt the New Subsidiary from being deemed
a Subsidiary (as defined in the Note Purchase Agreement) for purposes of
compliance with the negative covenants contained in the Note Purchase Agreement,
(iii) exclude any Indebtedness (as defined in the Note Purchase Agreement) of
the New Subsidiary for purposes of determining compliance with the financial
covenants contained in the Note Purchase Agreement and (iv) permit the Company
to make investments in the New Subsidiary in an aggregate amount necessary to
pay accrued interest on the Sheridan Acquisition Indebtedness (as defined in the
Note Purchase Agreement Amendment) through a certain date set forth in the Note
Purchase Agreement Amendment. The terms of the Note Purchase Agreement Amendment
are more fully described in the Note Purchase Agreement Amendment, a copy of
which is filed as Exhibit 10.2 to this Current Report on Form 8-K and is
incorporated herein by reference.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant.

On June 27, 2014, the Company entered into an amendment to its Revolving Credit
Agreement, the material terms and conditions of which are described in Item 1.01
of this Current Report on Form 8-K and are incorporated by reference into this
Item 2.03.

On June 27, 2014, the Company entered into an amendment to its Note Purchase
Agreement, the material terms and conditions of which are described in Item 1.01
of this Current Report on Form 8-K and are incorporated by reference into this
Item 2.03.

Item 8.01. Other Events.

On July 2, 2014, the Company issued a press release announcing that it had
closed its concurrent public offerings of 9,775,000 shares of its common stock
and 1,725,000 shares of its 5.250% Mandatory Convertible Preferred Stock, Series
A-1. Included in these amounts are 1,275,000 shares of common stock and 225,000
shares of Mandatory Convertible Preferred Stock, Series A-1, sold pursuant to
the underwriters' exercise in full of their options to purchase additional
shares in each offering. A copy of the press release is attached as Exhibit 99.1
to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Exhibits.
(d)
10.1 Seventh Amendment to Revolving Credit Agreement and Limited Consent, dated
as of June 27, 2014, among AmSurg Corp., the banks and other financial
institutions from time to time party thereto, and SunTrust Bank, in its
capacity as Administrative Agent for the lenders.
10.2 Fifth Amendment to Note Purchase Agreement and Limited Consent, dated as
of June 27, 2014, among AmSurg Corp. and the holders of Notes party
thereto.
99.1 Press release of AmSurg Corp., issued July 2, 2014.